Science and Research

Sefaxersen beat placebo on a week-37 urine protein measure, but Roche and Ionis have not disclosed the size of the effect or safety rates.

The Molecular and Clinical Genetics Panel votes Wednesday on whether the multi-cancer blood test is safe, effective and worth its risks.

The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis

Aduhelm's troubled journey and the pursuit of new horizons

Substances being produced at a more rapid rate this year will include psilocybin, DMT and delta-9 THC

The key partners for the new research facility will be announced in the coming months

A 50 milligrams dose of TruCBN significantly improved sleep disturbances

In clinical settings, a racemic mixture of both R and S ketamine is commonly used

The findings are particularly significant for depression and related mental health conditions, according to MindBio researchers.

After three hours, researchers noticed that the effect wore off and the mice recovered their fertility

The companies are already planning a second set of experiments with the goal of progressing to flight tests

New clinical research will assess efficacy of IV formulation for the treatment of strokes

Application follows successful pre-clinical animal studies at the University of Arkansas

Canadian biopharmaceutical company will receive government tax incentive for studies down under

Multi-disciplinary controlled substance company set to commence operations at Calgary facility

Flexible new curriculum designed to help students into cannabis career paths

FDA-approved psilocin study in California said to be first of its kind for industry

Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing new therapies

Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector

Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction

Company announces development of novel intranasal formulation with promising efficacy

New academic journal spotlights potential for rare cannabinoids to treat skin conditions

Dimethyltryptamine continues to demonstrate tremendous therapeutic potential

Canadian company set to focus clinical trials down under, announces regulatory update

Many distributors are choosing not to test their products for microbes, pesticides and heavy metals

Up to 37 per cent experienced positive side effects such as feeling active, energetic, "frisky" or productive

The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds

But whether or not the disruption helps with the substance's antidepressant properties still needs further research

The study also found that seven out of ten patients did not suffer from adverse effects

Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience

NFL players aren't allowed to participate in the research

But the results reinforce the view that laws based on blood-THC tests aren't supported by evidence

The study adds to a body of emerging research suggesting pot is effective in reducing opioid use

Substances helped lower people's anxiety and shame, but also lead to riskier sexual behaviours

Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa

The largest increase in drivers with moderate injuries was seen in men over 50

A recent study suggests the method could be used in roadside assessments of impaired driving from THC

Certain cannabinoids appear to block the virus from attaching to the 'doorway' of the cell

Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects

The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market